Prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in 41 children with cancer - A prospective study

被引:47
作者
Ruud, E [1 ]
Holmstrom, H
Natvig, S
Wesenberg, F
机构
[1] Natl Hosp Norway, Dept Pediat, N-0027 Oslo, Norway
[2] Natl Hosp Norway, Dept Radiol, N-0027 Oslo, Norway
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 2002年 / 38卷 / 06期
关键词
venous thrombosis; central venous catheter; thrombophilia; cancer in children;
D O I
10.1002/mpo.10062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. This study was designed to prospectively evaluate the prevalence of thrombophilia and central venous catheter-associated neck vein thrombosis in children with cancer. Procedure. Children with cancer and central lines, treated at the National Hospital in Norway, were consecutively enrolled in the study. Biochemical analysis of thrombophilia and Doppler ultrasonography of neck veins were performed at inclusion, and ultrasonography was repeated 3-5 months later. We recorded systematically positive blood-cultures and days with intravenous antibiotics. In a subgroup of 13 patient., with acute lymphoblastic leukaemia, the thrombophilia parameters were re-evaluated during asparaginase therapy, Results. Forty-one children were included in the study and observed for a mean of 266 days (range 95569 days). Eighteen patients (44%) developed venous thrombosis (VT), visualized by Doppler ultrasonography of the catheterized vein. Some clots were transient, but blood clots with diameters > 0.5 cm (n = 11) had a tendency to remain (P = 0.14). Twelve children (29%) were classified as thrombolphilic at inclusion, with elevated serum levels of homocysteine and lipoprotein(a) as the most frequent alterations. Transient thrombophilia developed in all patients during asparaginase-therapy. Within the limitations of our study, we did not find any significant correlation between thrombophilia and development of VT, nor thrombosis and infectious disease, Conclusions. VT develops frequently in paediatric cancer patients with central lines, but the clinical implication of this observation remains to be clarified. Med Pediatr Oncol 2002;38:405-410. (C) 2002 Wiley-Lis, Inc.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 30 条
[21]   A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis [J].
Poort, SR ;
Rosendaal, FR ;
Reitsma, PH ;
Bertina, RM .
BLOOD, 1996, 88 (10) :3698-3703
[22]  
Prandoni P, 1999, HAEMATOLOGICA, V84, P437
[23]   THE RELATIONSHIP BETWEEN THE THROMBOTIC AND INFECTIOUS COMPLICATIONS OF CENTRAL VENOUS CATHETERS [J].
RAAD, II ;
LUNA, M ;
KHALIL, SAM ;
COSTERTON, JW ;
LAM, C ;
BODEY, GP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13) :1014-1016
[24]   Central venous catheter use and the risk of infection in children with acute lymphoblastic leukemia: A report from the Children's Cancer Group [J].
Rackoff, WR ;
Ge, J ;
Sather, HN ;
Cooper, HA ;
Hutchinson, RJ ;
Lange, BJ .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (04) :260-267
[25]   Benefit of heparin in central venous and pulmonary artery catheters - A meta-analysis of randomized controlled trials [J].
Randolph, AG ;
Cook, DJ ;
Gonzalez, CA ;
Andrew, M .
CHEST, 1998, 113 (01) :165-171
[26]   Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism [J].
Schulman, S ;
Lindmarker, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26) :1953-1958
[27]  
SHAPIRO AD, 1993, AM J PEDIAT HEMATOL, V15, P400
[28]  
Simioni P, 2000, BLOOD, V96, P3329
[29]  
Taylor A, 1998, J Emerg Med, V16, P663, DOI 10.1016/S0736-4679(98)00050-X
[30]   Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters [J].
Wermes, C ;
Prondzinski, MV ;
Lichtinghagen, R ;
Barthels, M ;
Welte, K ;
Sykora, KW .
EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (Suppl 3) :S143-S146